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Size (nm) 
 
 
PDI 
 
Zeta Potentiel (mV) 
TBA2 - PLGAa 85.7 ± 4.9 0.12 ± 0.02 -25.8 ± 4.4 
CMIF - PLGAa 102.0 ± 2.6 0.16 ± 0.01 -38.2 ± 1.7 
CMB - PLGAa 75.7 ± 2.5 0.16 ± 0.02 -22.4 ± 9.8 
    
TBA2 - PLGAb 95.0 ± 6.1 0.12 ± 0.01 -42.2 ± 8.0 
CMIF - PLGAb 124.7 ± 2.5 0.08 ± 0.02 -47.8 ± 4.6 
CMB - PLGAb 99.3 ± 4.6 0.12 ± 0.01 -47.8 ± 9.1 
    
TBA2 - PLGAc 141.7 ± 6.4 0.09 ± 0.02 -24.8 ± 1.3 
CMIF - PLGAc 144.7 ± 4.7 0.09 ± 0.03 -31.5 ± 3.6 
CMB - PLGAc 118.3 ± 4.3 0.12 ± 0.01 -43.1 ± 6.5 
 
Characterizations 
P/C ratio a) 1; b) 2.5 and c) 5 
365 nm 
*Graphical Abstract (for review)
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ABSTRACT 24 
We present a screening of poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles embedding a 25 
series of inorganic molybdenum octahedral clusters intended for photodynamic therapy (PDT) 26 
of cancer. Three cluster compounds from 2 cluster units, [{Mo6Br}8Br6]
2-
 and 27 
[{Mo6I8}(OOC2F5)6]
2-
 were studied. [{Mo6Br}8Br6]
2-
cluster units are found in the soluble 28 
ternary salt Cs2[{Mo6Br}8Br6] (CMB) prepared by solid state chemistry at high temperature.  29 
In solution Cs
+
 cations are replaced by tetrabutyl ammonium cations (C4H9)4N
+
) to form the 30 
salt ((C4H9)4N)2[{Mo6Br}8Br6] (TBA2). [{Mo6I8}(OOC2F5)6]
2-
  was prepared combining solid 31 
state and solution chemistries; it is paired with Cs
+
 cations to form Cs2[{Mo6I8}(OOC2F5)6] 32 
(CMIF).
 
All tested cluster-based salts could efficiently be incorporated in PLGA nanoparticles 33 
as seen with encapsulation efficiencies always higher than 60%. Cluster loaded nanoparticles 34 
(CNPs) freshly prepared by solvent displacement method showed spherical shapes, zeta 35 
potential values between -20 and -47mV, polydispersity index in the range 0.123-0.167 and 36 
sizes in the range 75-150 nm according to the cluster compound and the polymer-to-cluster 37 
mass ratio (P/C), suggesting a good cellular uptake. CNPs colloidal stability was maintened 38 
for 3 months when they were stored refrigerated and protected from light but the chemical 39 
stability was shorter, i.e. 4 weeks, 1 week and 1 day for CMIF, TBA2 and CMB, respectively, 40 
CMIF penta-fluoropropionate apical ligands being less rapidly substituted by hydroxyles 41 
groups than TBA2 and CMB halogen apical ligands. FT-IR analysis revealed the lack of 42 
strong chemical interaction between cluster compounds and polymer within the nanoparticles. 43 
An interesting quick cluster in vitro release driven by diffusion outside the nanoparticles 44 
porous matrix was observed for all cluster compounds when P/C ratio was ≤ 2.5 and only a 45 
higher P/C ratio not studied in this work (i.e > 5) could significantly affect the release of the 46 
encapsulated cluster compound. Photophysical properties of cluster compounds were 47 
preserved following PLGA incorporation. This work presents PLGA nanoparticles as a stable 48 
and efficient cluster compound delivery systems for further in vitro and vivo evaluations in 49 
cancer models.
 
50 
 51 
Key words: PLGA nanoparticle, molybdenum cluster, physico-chemical properties, colloidal 52 
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1. INTRODUCTION 55 
 56 
Hexanuclear cluster of molybdenum with the general formula [Mo6(L
i
)8(L
a
)6]
2−
 (Figure 1) 57 
have been widely studied due to their photo-physical and photo-chemical properties (Jackson 58 
et al., 1996; Kirakci et al., 2012; Costuas et al., 2015; Dierre et al., 2017). In these clusters, 59 
inner ligands (L
i
) are halogen atoms (Br, I, Cl) covalently attached to Mo, forming the stable  60 
{Mo6L
i
8}
4+
 cluster core, while terminal or apical ligands (L
a
) are labile inorganic or organic 61 
ligands that are able to affect the physico-chemical properties of the cluster compound. When 62 
they are photo-activated near 365 nm, the very highly chemical and photo-stable cluster cores 63 
{Mo6L
i
8}
4+
 show bright photoluminescence with broad emission spectra in the red and near-64 
infrared regions (from 550 to 900 nm) with high quantum yields (Vorotnikov et al., 2017; 65 
Kirakci et al., 2012; Efremova et al., 2016). When the photo-activation occurs in the presence 66 
of oxygen, they can act as powerful photosensitizers generating singlet oxygen efficiently 67 
(Kirakci et al., 2012; Jackson et al., 1990; Amela-Cortes et al., 2015). Such physical and 68 
chemical properties make molybdenum cluster compounds very attractive in many biological 69 
sciences applications such as bioimaging, biolabeling, diagnostics, cell destructing or 70 
antimicrobial agents (Vorotnikova et al., 2019; Solovieva et al., 2016; Neaime et al., 2016). 71 
As a result, hexanuclear molybdenum halide cluster complexes are potential candidates for 72 
theranostic applications (Ahmed et al., 2012). Because of the poor solubility and stability of 73 
these cluster compounds in water, the most physiological solvent for biological applications, 74 
there is a need to incorporate them into biocompatible delivery systems such as polymeric 75 
nanoparticles that will improve the cluster compound i) apparent solubility, ii) protection 76 
against hydrolysis and iii) release in tumor areas. Several works have reported the use of 77 
water soluble hybrid materials of molybdenum clusters (Kirakci et al., 2016; Svezhentseva et 78 
al., 2017) or the encapsulation of molybdenum cluster compounds in matrixes less 79 
biocompatible for parenteral injection such as silica nanoparticles (Aubert et al., 2013; 80 
Solovieva et al., 2016) or nano-sized polystyrene beads (Vorotnikova et al., 2017). In a 81 
previous work our team has shown the feasibility of incorporating a molybdenum cluster 82 
compound into poly (D,L-lactide-co-glycolide) (PLGA) nanoparticles to maintain their 83 
intrinsic photophysical properties and to use them as photosensitizer after entering the ovarian 84 
cancer cells leading to their destruction (Brandhonneur et al., 2018). Nevertheless, the activity 85 
and stability of the formulation can be improved by selecting the most appropriate cluster 86 
compound and by an optimization of the polymer-to-cluster mass ratio (P/C). The aim of the 87 
present study was to prepare PLGA nanoparticles (NPs) embedding a series of inorganic 88 
 4 
hexanuclear molybdenum cluster compounds intended for PDT of ovarian cancer and to 89 
select the most stable and efficient association for further in vitro and in vivo studies. The 90 
polymeric nanoparticles were tested as a carrier system for molybdenum cluster compounds 91 
to circumvent their poor aqueous solubility. Three cluster compounds from 2 cluster units, 92 
[{Mo6Br}8Br6]
2-
 and [{Mo6I8}(OOC2F5)6]
2-
 were studied. [{Mo6Br}8Br6]
2-
 cluster units are 93 
found in the soluble ternary salt Cs2[{Mo6Br}8Br6] (CMB) prepared by solid state chemistry 94 
at high temperature. In solution Cs
+
 cations are replaced by tetrabutyl ammonium cations 95 
(C4H9)4N
+
) to form the salt ((C4H9)4N)2[{Mo6Br}8Br6] (TBA2). [{Mo6I8}(OOC2F5)6]
2-
  was 96 
prepared combining solid stae and solution chemistries; it is paired with Cs
+
 cations to form 97 
Cs2[{Mo6I8}(OOC2F5)6] (CMIF). These cluster compounds loaded nanoparticles (CNPs) were 98 
prepared by solvent displacement method using polysorbate 20 as stabilizer and carboxylic 99 
acid terminated poly (D,L-Lactide-co-glycolide) (PLGA) polymer with a 50:50 lactide to 100 
gycolide ratio. Several polymer-to-cluster mass ratios (P/C) were tested, 1, 2.5 and 5. CNPs 101 
were characterized using transmission electron microscopy or TEM (size and shape), dynamic 102 
light scattering or DLS (size, polydispersity index, zeta potential, colloidal stability over 3 103 
months), Fourier transform infrared spectroscopy or FT-IR (cluster/polymer interactions), UV 104 
spectroscopy (encapsulation efficiency or EE, drug loading or DL, water stability and drug 105 
release behavior). Finally, the effect of PLGA nanoparticles incorporation on cluster 106 
compound photochemical parameters that can influence the generation of oxygen singlet, i.e. 107 
absolute quantum yields and maximum emission wavelengths, were evaluated.  108 
 109 
 110 
2. MATERIAL AND METHODS 111 
2.1. Chemicals 112 
CMB was synthesized by solid state reaction techniques at high temperature whereas TBA2 113 
and CMIF were prepared by combining solid state reactions and solution chemistry routes in 114 
our laboratory (ISCR, CSM, Rennes, France) using reported procedures (Kirakci et al., 2005, 115 
Amela-Cortes et al., 2015). Acid terminated PLGA with a 50:50 lactide to gycolide ratio, MW 116 
24000-38000 (Resomer
®
 RG503H) and polyoxyethylenesorbitan monolaurate or polysorbate 117 
20 (Tween
®
 20) were purchased from Sigma Aldrich (St Louis, MO, USA). Analytical 118 
reagent grade acetone, acetonitrile and absolute ethanol were obtained from VWR 119 
international S.A.S. (Fontenay-sous-bois, FR).  120 
 5 
2.2. Nanoparticles preparation 121 
CNPs and cluster free nanoparticles or blank nanoparticles were prepared by solvent 122 
displacement method or nanoprecipitation, described by Fessi et al. (1989). An organic 123 
solution of PLGA polymer (10 to 50 mg) and cluster compound (9-13 mg according to its 124 
molecular weight) in acetone (5 ml) was slowly added dropwise (1 ml/min) to a 0.5% w/v 125 
aqueous polysorbate 20 solution (15 ml) with a 5 ml syringe and a 25G (0.5mm x 16 mm) 126 
needle (Terumo Europe, Leuven, Belgium) under magnetic stirring (500 rpm) at room 127 
temperature (20-25°C°). In these conditions, a bluish colloidal nanosuspension was 128 
instantaneously formed owing to the ouzo effect (Francois et al., 2005). The acetone was then 129 
removed under reduced pressure (200 mbar) by a rotary evaporator Laborata 4000 (Heidolph, 130 
Schwabach, Germany) for 1h. The nanosuspensions (≃ 15 ml) were then purified by a first 131 
step of centrifugation (5000 g / 5 min) to eliminate polymer aggregates and by a second step 132 
of dialysis against 1 liter of deionized water for 1h to eliminate free cluster, using 133 
Spectra/Por®6 pre-wetted dialysis membrane with a molecular weight cut-off of 25kD 134 
(Spectrum Laboratories, Inc, Rancho Dominguez, CA, USA). The resulting nanosuspensions 135 
were used for size, PDI and zeta potential determinations, encapsulation efficiency, cluster 136 
loading, water stability evaluation, release studies and quantum yields measurements. CNPs 137 
physico-chemical characterizations performed in solid state, such as FT-IR, quantum yields 138 
and emission spectra needed a freeze-drying stage of cluster loaded nanosuspensions for 24 h 139 
using a Christ®Alpha laboratory freeze-drier, (Martin Christ, Germany). 140 
 141 
2.3. Nanoparticles characterization 142 
2.3.1. Particles size, polydispersity index and zeta potential 143 
All three CNPs mean hydrodynamic diameters (nm) and polydispersity indexes (PDI) were 144 
determined by laser dynamic light scattering (DLS), and their zeta potentials (mV) were 145 
determined by laser droppler micro-electrophoresis technique using Malvern Zetasizer Nano 146 
ZS (Malvern Instruments, Malvern, United Kingdom). For each CNPs, all measurements were 147 
carried out in triplicate (from 3 different batches) following appropriate sample dilution with 148 
distilled water, immediately after preparation and following 1, 2, 7, 14, 30, 60 and 90 days 149 
storage protected from light, at room temperature and refrigerated between +2 and +8°C.  150 
 151 
 6 
2.3.2. Encapsulation efficiency, cluster loading and mass yield 152 
Cluster compounds encapsulation efficiency (EE%) as well as cluster compounds loading in 153 
polymeric nanoparticles (CL%) were determined by UV spectroscopy at 250 nm following 154 
appropriate dilution with acetonitrile (Specord®PC 205 UV VIS spectrophotometer, Analytik 155 
Jena AG, Jena, Germany). Cluster calibration curve was linear from 2 to 20 µg/ml (r
2
 = 156 
0.99991). Encapsulation efficiency determinations were performed immediately after 157 
preparation following centrifugation of the CNPs suspensions at 40000 g for 30 min (Sigma 158 
3K20 high speed refrigerated centrifuge). Free or non-encapsulated cluster compounds were 159 
collected from supernatant, diluted with acetonitrile and concentrations were determined by 160 
UV spectroscopy at 250 nm.  161 
EE or the ratio of the experimental percent cluster loaded in the polymeric nanoparticles to the 162 
initial amount of cluster in the formulation was calculated according the following equation: 163 
 164 
        
                                                            
                            
       
 165 
Cluster loading (CL %) was performed by centrifugation of the CNPs suspension at 40000 g 166 
for 30 min followed by freeze-drying of the sediment for 24h, after re-dispersion in distilled 167 
water. A known amount of CNPs close to 5 mg was dissolved in 2 ml acetonitrile, diluted 168 
(1/50) with acetonitrile and assayed for cluster quantification using the previous UV method. 169 
CL or the percent cluster in the freeze dried polymeric nanoparticles was calculated according 170 
the following equation: 171 
       
                                                       
                                      
       
 172 
Mass yields (MY%) of the formulations were also determined using the equation: 173 
       
                                               
                                              
       
 174 
2.3.3. Transmission Electron Microscopy (TEM) 175 
CNPs morphologies were examined with a transmission electron microscope (TEM, JEOL 176 
2100, Japan) and charge coupled device camera Orius 200D (GatanInc, Pleasanton, USA). 177 
Samples were prepared by placing a drop of CNPs nanosuspensiononto a carbon coated 178 
copper grid and air-dried, following negative staining during 3 min with one drop of 2% 179 
 7 
aqueous solution of uranyl acetate for contrast enhancement. The air-dried samples were then 180 
directly examined under the transmission electronic microscope. 181 
 182 
2.3.4. Fourier Transform Infrared Spectroscopy (FT-IR) 183 
PLGA Polymer (RG503H), cluster compounds TBA2, CMB and CMIF, freeze dried blank 184 
nanoparticles, freeze dried CNPs as well as physical mixtures between cluster compounds and 185 
polymer with P/C ratios of 1, 2.5 and 5 were all analyzed by infrared spectroscopy using 186 
Universal Attenuated Total Reflectance Accessory (UATRA) Spectrum Two™ FT-IR 187 
Spectroscopy (Perkin Elmer Inc., Massachusetts, USA). Samples were fixed on the diamond 188 
crystal and a pressure of 90 N/cm
2 
was applied to each sample. Spectra were recorded in the 189 
range from 500 to 4000 cm
−1 
and analyzed using Spectrum
®
 Quant software.  190 
 191 
2.3.5. Cluster compound chemical stability in aqueous nanosuspensions 192 
Chemical stabilities of cluster compounds in CNPs were shown with 2 complementary 193 
approaches, i) their UV-visible absorption spectra evolution from preparation up to 48 hours 194 
and ii) the evolution of cluster compound concentrations in aqueous nanosuspensions during 4 195 
weeks by UV spectroscopy at 250 nm as described in section 2.3.2. In both studies 196 
nanosuspensions were refrigerated and protected from light and measurements were 197 
performed following appropriate dilution with acetonitrile using a Specord®PC 205 UV VIS 198 
spectrophotometer (Analytik Jena AG, Jena, Germany).  199 
 200 
2.4 In vitro cluster release from CNPs  201 
Cluster compounds release analysis from nanoparticles were carried out in absolute ethanol at 202 
25°C, respecting the “sink” condition, i.e. cluster compound solubility in the dissolution 203 
medium never exceeding 10% of its solubility. At the beginning of the experiment, 4.5ml of 204 
freshly prepared CNPs corresponding to 2 to 4 mg of cluster compounds were placed in a 205 
dialysis bag, a 25kD MWCO Spectra/Por®6 pre-wetted dialysis membrane (Spectrum 206 
Laboratories, Inc, Rancho Dominguez, CA, USA) then sealed at its 2 sides and placed in a 207 
150 ml beaker containing 100 ml release medium with continuous magnetic stirring (250 208 
rpm). The sampling conditions were depending on the cluster compound chemical stability in 209 
the aqueous nanosuspensions. The quick substitution of the halogen Br
-
 labile terminal ligands 210 
of the [{Mo6Br}8Br6]
2-
 cluster units with hydroxyl groups or water molecules described in 211 
 8 
section 3.2 is leading to an apparent decrease in the percent released profile as a function of 212 
time. To overcome this situation, percent cluster released was obtained from the percent 213 
cluster remaining in the dialysis bag at the sampling time. At each sampling time (30, 60, 180, 214 
360 and 1440 and 2880 min) the flask was centrifuged (5000 g /10 min) the supernatant was 215 
discarded, the nanoparticles in sediment were solubilized in 5 ml acetonitrile and the percent 216 
cluster released was evaluated by UV spectrophotometer at 250 nm after dilution (1/20) with 217 
acetonitrile using the method mentioned in section 2.3.2. For CMIF, the apical ligand 218 
substitution kinetics was much slower than for [{Mo6Br}8Br6]
2-
 cluster unit based salts and 219 
direct sampling in the donor compartment was possible at each sampling time. Each point 220 
represents the mean ± SD of 3 different batches. 221 
 222 
2.5. Photophysical studies 223 
Absolute photoluminescence quantum yields, em, were measured on powdered cluster 224 
compounds and on CNPs (as aqueous nanosuspensions or freeze-dried solid nanoparticles) 225 
using a Hamamatsu C9920-03G measurement system (Hamamatsu Photonics France, Massy, 226 
France) comprising a xenon excitation light source, an integrating sphere and a red-sensitive 227 
multichannel photodetector Hamamatsu PMA-12. The excitation wavelength was set at 365 228 
nm. The same Hamamatsu set up was used to obtain emission spectra. 229 
 230 
2.6. Statistical analysis 231 
All experiments were performed in triplicate. Results are presented as mean ± SD. Mean 232 
values of nanoparticle size, PDI, zeta potential and encapsulation efficiency were compared 233 
using the Mann and Whitney test and differences were considered significant at the level of p 234 
< 0.05.  235 
 236 
 237 
 238 
 239 
 240 
 241 
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3. RESULTS AND DISCUSSION 242 
3.1. Nanoparticles formulation and characterization 243 
PLGA nanoparticles were prepared by the solvent displacement method also known as nano-244 
precipitation method (Fessi et al., 1989). The oily phase or organic phase is a solution of 245 
acetone in which both cluster compound and PLGA polymer are dissolved while the aqueous 246 
phase is a distilled water solution of surfactant polyoxyethylenesorbitan monolaurate. Cluster 247 
loaded polymer nanosuspensions were obtained following dropwise addition of the organic 248 
phase to the aqueous phase. Particle size is one of the most critical factor to consider for the 249 
cellular uptake of colloidal system, sizes between 50-150 nm are needed for optimal uptake 250 
by tumor cells (He et al., 2010). Following acetone removal under reduced pressure and using 251 
the preparation conditions described in section 2.2, several cluster nanoparticles (CNPs) were 252 
obtained with 3 different P/C ratios, i.e 1, 2.5 and 5. Table 1 shows the nanoparticle sizes, 253 
polydispersity indexes (PDI) and zeta potential obtained for all freshly prepared formulations. 254 
All nanoparticles sizes obtained were compatible with a cellular uptake, higher sizes were 255 
obtained with CMIF the cluster salt with the higher atomic mass and significant variations in 256 
nanoparticle sizes were observed when the tested P/C ratio was increased from 1 to 5, with 257 
sizes increasing from the range 75-100 nm (P/C = 1) to the range 120-145 nm (P/C = 5). This 258 
result is in accordance with other studieson PLGA concentration effect on nanoparticles size 259 
and this may be due to an increase of the solution viscosity (Halayqa et al., 2014; Homs et al., 260 
2018). PDI values were always < 0.2 indicating a homogenous monodispersed profile of the 261 
prepared nanoparticles but this time a significant decrease was observed when P/C ratio was 262 
increased from 1 to 5, i.e. 33%, 77% and 33% for TBA2, CMIF and CMB, respectively, 263 
indicating a narrowing of size distribution with higher P/C ratio. Zeta potentials were all 264 
comprised between -25 and -45 mV, measuring the negative electric charge on the 265 
nanoparticle surface resulting from the interaction between PLGA and the polysorbate 20 266 
surfactant. 267 
Zeta potential absolute values higher than 30 mV are generally related to better nanoparticle 268 
physical stabilities due to stronger electrostatic repulsion between nanoparticles (Gupta and 269 
Trivedi, 2018), the highest Zeta potential values were obtained with the P/C ratio of 2.5, 270 
whatever the cluster compound tested. The encapsulation efficiencies (EE%), cluster loadings 271 
(CL%) and mass yields (MY%) obtained for each CNPs were determined using UV 272 
spectrophotometry and the results are reported in Table 2. The EE was higher than 60% for all 273 
 10 
P/C ratios tested indicating an efficient cluster entrapment within the nanoparticles. Among 274 
the cluster compounds tested, only CMIF-PLGA reached an EE% higher than 95%. CLs were 275 
as expected significantly decreased when P/C ratio was increased. The MY% vas evaluated 276 
after freeze-drying of the samples and no statistically significant differences were observed 277 
between the different P/C ratios tested. 278 
TEM was performed to examine CNPs morphology. For each cluster compound tested, all 279 
P/C ratios showed the same morphology, therefore only nanoparticles with a P/C ratio of 2.5 280 
were presented in Figure 2A. TEM images show the spherical shape and the porous structure 281 
of CNPs prepared by nanoprecipitation, the particle size, around 50 nm were always lower 282 
than those obtained with dynamic light scattering as already reported and commented in our 283 
previous study with TBA2 (P/C = 0.5) (Brandhonneur et al., 2018). Figure 2B presents freshly 284 
prepared CNPs with a P/C ratio of 2.5 under daylight (left) and following photo-activation 285 
under UV light at 365 nm (right) exhibiting eye-observable intensive red luminescence for 286 
CMIF and less intensive pink to red luminescence, according to P/C ratio for CMB and TBA2. 287 
 288 
Fourier Transform Infrared spectroscopy was performed to investigate the polymer/cluster 289 
interactions resulting from the cluster encapsulation in the nanoparticles. As PLGA is an 290 
organic polymer , it is easy to follow the shifts concerning well characterized vibrations such 291 
as C=O stretching or carbonyl bond at 1750cm
-1
, C-O ester stretching at 1088cm
-1
 and sp3 C-292 
H stretching at 1750cm
-1
. The results obtained for blank polymeric nanoparticles and CNPs 293 
are given in Table 3. The C=O stretch recorded for the polymer at 1750 cm
-1 
did not change in 294 
CNPs while the peak representing the C-O ester stretching slightly moved from 1088 cm
-1 
for 295 
the polymer to 1078 cm
-1
 and 1083 cm
-1 
for both molybdenum halide CNPs with a P/C ratio 296 
of 2.5, TBA2 and CMB, respectively. The vibration corresponding to the sp3 C-H stretching 297 
was detected at 2914 cm
-1 
for the polymer and moved significantly between 2921 and 2924 298 
cm
-1 
for all CNPs tested, indicating the existence of interactions between the polymer and the 299 
cluster compound. Nevertheless, FT-IR spectra show the presence of all polymer 300 
characteristic peaks and the absence of new chemical modifications creation following cluster 301 
compound incorporation into nanoparticles (data not presented), this clearly indicates the lack 302 
of strong chemical interactions formed but rather physical ones. This comes in accordance 303 
with other studies on PLGA nanoparticles incorporating drugs such as methotrexate, garcinol 304 
or hesperidin where authors concluded to the lack (Jang et al., 2019; Gaoncar et al., 2017) or 305 
to minor (Ali et al., 2019) chemical interaction between drug and polymer. 306 
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3.2. CNPs Physico-chemical stability 307 
CNPs physical stability is an essential parameter in formulation. The colloidal stability of 308 
polymeric nanoparticles can be monitored by the change of particle size, PDI and zeta 309 
potential at a function of time following storage in close vials protected from light, at ambient 310 
temperature (+25°C) or refrigerated (between +2 and +8°C). For blank PLGA nanoparticles, 311 
colloidal stability was conserved during the 3 months study whatever the temperature 312 
(Supplementary material 1). Figure 3 shows the evolution of size, PDI and Zeta Potential 313 
following dynamic light scattering measurements on a 3 months storage period for the 314 
nanosuspensions refrigerated between +2 and +8°C and protected from light. Particle sizes 315 
were not statistically modified during the 3 month of storage for all cluster compounds and all 316 
P/C ratios tested, only a slight increase in size, always below 5%, was measured over the 317 
period. Identically, PDI were not significantlty modified, all values were comprised between 318 
0.09 and 0.19, showing the conservation of size distribution over time. Zeta potential values, 319 
predictor of nanoparticles medium or long term instability, increased rapidly after 320 
nanoparticle preparation, up to 50% at day 7 and were approaching zero after 1 month. This 321 
decrease in Zeta potential values not observed with blank nanoparticles may be related to 322 
cluster compound hydrolysis and the creation of new chemical species perturbing the 323 
nanoparticles environment thus limiting CNPs physical stability to 3 months under 324 
refrigeration. These rapid decrease of zeta potential values were also confirmed when the 325 
nanosuspensions were stored at ambient temperature (25 ± 1°C) and protected from light 326 
(Supplementary material 2) but this time, size was significantly increased after 2 months for 327 
TBA2 (8 fold increase) and CMB (2 fold increase) loaded nanoparticles only with P/C ratio of 328 
1, while size was not modified during the period for CMIF. We can conclude that i) keeping 329 
the nanosuspensions refrigerated is delaying the manifestation of instability; ii) zeta potential 330 
is a critical parameter to predict a forthcoming instability; iii) increasing polymer 331 
concentration improves nanoparticle stability and iv) using pentafluoro propionate as organic 332 
apical ligand instead of brome seems to protect nanoparticles from aggregation. Chemical 333 
stabilities of cluster compounds were also checked by following the evolution of absorption 334 
spectra of aqueous nanosuspensions and by determination of cluster compounds 335 
concentrations in nanosuspensions by UV spectroscopy at 250 nm. The UV-visible absorption 336 
spectra of freshly prepared nanosuspensions of TBA2, CMIF and CMB, as well as their 337 
evolution for 48h (at 0, 3, 6, 24 and 48 hours) were recorded in acetonitrile and are shown in 338 
figure 4. For CMIF all spectra from 0 to 48 hours are superposed signing the lack of chemical 339 
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modification during the period studied while for the 2 other clusters with brome as apical 340 
ligand, the intensity of the UV absorption maximum around 250 nm was continually 341 
decreasing during the same period and for TBA2 a second UV absorption peak near 217 nm 342 
was increasing, corresponding to the formation of a new chemical compound as shown with 343 
the isosbestic point at 230 nm. In fact, molybdenum cluster compounds are known to be 344 
unstable in water where they are converted into aqua hydroxo complexes by substitution of 345 
labile apical ligand by hydroxyl groups or water molecules leading to micron sized aggregates 346 
with altered luminescence properties (Daigre et al., 2018; Kirakci et al., 2016, 2019; 347 
Svezhentseva et al., 2017). Encapsulating the cluster in a matrix such as SiO2 nanoparticles 348 
(Aubert et al., 2013), polystyrene microparticles (Efremova et al., 2014) or nanoassemblies 349 
with betacyclodextrins (Kirakci et al., 2014) was shown to be a solution to circumvent the 350 
tendency to easily hydrolyse in water. In our study the use of a porous biocompatible 351 
polymeric matrix is interesting with fluoropropionate organic apical ligand, as seen with 352 
CMIF that can, contrary to halogen ligand protect the Mo6I8 cluster core from water 353 
hydrolysis and this was also observed with a similar cluster core with fluorinated apical ligand 354 
presented as colloidal nanodispersion (Kirakci et al., 2018). This was also confirmed by the 355 
UV assay of cluster compound in the nanoparticles during 4 weeks (figure 5). 356 
The percent cluster compound remaining unchanged at a function of time from CNPs was 357 
better for CMIF (lack of cluster loss after one week; <10% loss after 4 weeks) than for the 358 
two other cluster compounds, TBA2 (10% and 30% loss after 1 and 4 weeks, respectively) and 359 
CMB (30% and > 50% loss after 1 and 4 weeks, respectively). This time again CMIF was the 360 
most protected within the PLGA matrix for up to 4 weeks due to the shielding effect of the 361 
organic apical ligand.  362 
As shown in our previous study, release of cluster compound from CNPs is needed for an 363 
optimal activity following photo-activation (Brandhonneur et al., 2018). Figure 6 presents the 364 
percent cluster released as a function of time for the 3 clusters and the 3 P/C ratios. As 365 
mentioned in material and methods section, in vitro release was performed in ethanol to 366 
respect the sink condition for the duration of the test. From percent released curves we can see 367 
a high initial burst for each cluster compound with more than 50% released at 180 min for all 368 
P/C ratios, followed by a prolonged release phase during the 48h test. The initial quantity 369 
released by burst effect is decreasing with P/C ratio for all cluster compounds, from 60-65% 370 
(P/C = 1) to 50% (P/C = 5) and this can be explained by the mechanisms of cluster release 371 
from PLGA nanoparticles that are drug diffusion in the porous matrix happening from the 372 
beginning followed by late polymer degradation by ester linkages hydrolysis. The cluster 373 
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compound diffusion is improved with low P/C ratio due to a smaller polymeric matrix. In the 374 
same way, the lower the P/C ratio (i.e.1), the higher the percent released at 24h, i.e. 88%, 80% 375 
and 75% for CMIF, CMB and TBA2, respectively and the higher the P/C ratio (i.e. 5), the 376 
lower the percent released at 24h, i.e. 71%, 71% and 60%, for CMIF, CMB and TBA2, 377 
respectively. It is also possible to compare the different profiles by estimating the time needed 378 
to obtain 50% of release or t50%, and this parameter was always increasing with P/C ratio, i.e. 379 
from 77.2 to 138.9 min, 150.2 to 185.2 min and 24.8 to 171.2 min for CMIF, CMB and TBA2, 380 
respectively, when P/C ratio was increased from 1 to 5. There was a slight effect of P/C ratio 381 
on the release of the cluster compound from nanoparticles, it seems that only a higher P/C 382 
ratio that was not studied in this work (i.e > 5) could significantly decrease the release of the 383 
encapsulated cluster compound thus affecting the production of singlet oxygen following 384 
photoactivation. 385 
 386 
3.3. Photophysical properties 387 
Molybdenum cluster compound are known to exhibit photoluminescence between 550 and 388 
900 nm with quantum yield up to 100% and luminescence lifetimes up to 400 µs (Vorotnikov 389 
et al., 2017; Kirakci et al., 2012; Efremova et al., 2016; Maverick et al., 1983). When metal 390 
cluster compounds are embedded into a polymeric matrix there is a need to check if the 391 
photophysical properties of the starting cluster compound are affected. For that purpose we 392 
compared the luminescence properties of the molybdenum cluster compounds before and after 393 
their incorporation into PLGA matrixes. Photophysical parameters for powdered pure cluster 394 
compounds CMB, TBA2 or CMIF and for their PLGA nanoparticulate systems presented in 395 
Figures 7, 8 and 9 (emission spectra) and Table 4 (photoluminescence absolute quantum 396 
yields or AQY). The irradiation of CNPs in the UV-Blue region is leading to the cluster 397 
emission in the red-near infrared (from 550 to 900 nm). Emission spectra were recorded from 398 
CNPs nanosuspensions and from solid state CNPs obtained after freeze drying of the 399 
nanosuspensions. From emission spectra (Figures 7, 8 and 9) we can observe a broad 400 
emission signal typical of metal clusters phosphorescence when they are irradiated in the UV-401 
blue region at 365 nm. Cluster compound incorporation in PLGA matrix does not lead to a 402 
modification of the general shape of its emission band, only a slight blue shift of emission 403 
signal could be guessed when CNPs were dispersed in water compared with their solid form, 404 
but no significant shift of the emission maximum (figure 7). A slight red shift of cluster 405 
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compound emission maximum (15 nm) could only be seen with CMIF following its 406 
incorporation into PLGA nanoparticles but no emission maximum shift could be detected 407 
when P/C ratio was modified (Figure 8). All these results are evidencing that cluster 408 
compounds emission properties are preserved when they are embedded into PLGA 409 
nanoparticles. 410 
AQY depend on the ratio of the emission and the absorption energy and thus characterize the 411 
ability of a sample to emit light following irradiation. An increase in the emission signal 412 
intensity was observed with CMIF loaded nanoparticles (P/C ratio = 2.5) when passing from 413 
an air to a N2 saturated atmosphere in the integrating sphere (Figure 9) and this phenomenon 414 
was reversible when N2 was replaced by air. Octahedral clusters compound excited state are 415 
known to efficiently react with triplet oxygen to form emissive singlet oxygen (Jackson et al., 416 
1990), resulting in a quenching of the cluster emission signal, i.e. its luminescence. The 417 
decrease in atmosphere dioxygen concentration obtained with N2 resulted in a decrease of 418 
cluster luminescence quenching. This phenomenon is a totally reversible physical 419 
phenomenon that does not lead to a chemical alteration of the emitting cluster, as seen with 420 
the lack of emission maximum shift. Incorporation of molybdenum clusters in polymeric 421 
PLGA network led to a decrease of AQY (Table 4) and this was also reported with several 422 
cluster compounds, ((C4H9)4N)2(Mo6I8)(NO3)6) (Vorotnikov et al., 2016), 423 
((C4H9)4N)2{Mo6I8}(CF3CO2)6) (Kirakci et al., 2012) and CMB (Aubert et al., 2013; Grasset 424 
et al., 2008) following their incorporation into SiO2 micro or nanoparticles and was also 425 
reported for Mo6 clusters after incorporation in PMMA (Amela-Cortes et al., 2016) or 426 
PMMA-PEOMA copolymer (Robin et al., 2018) matrixes, these modifications being 427 
attributed to perturbation of the ligand environment in the polymeric matrix or to cluster 428 
compound instability during nanoparticles preparation, i.e. apical ligand substitution by water 429 
molecules. The highest values were obtained for pure cluster compounds in solid state 430 
compared to CNPs and, as reported by Amela-Cortes at al. (2015, 2016), molybdenum cluster 431 
compound with organic apical ligand (CMIF) gave the higher AQY compared to clusters with 432 
halogen apical ligands (CMB and TBA2). AQY values were not significantly increased with 433 
cluster compound concentration (i.e. when decreasing P/C ratio) showing that cluster 434 
compound were absorbing most of the light at the excitation wavelength used, i.e. 365 nm. 435 
Because of the existence of interactions between the triplet excited state of cluster compounds 436 
and molecular oxygen, aerated water nanosuspensions were poorly emissive, as seen with 437 
AQY values of 6.6, 1.5 and 2% for TBA2, CMIF and CMB, respectively. For this reason 438 
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AQY values in freshly prepared nanosuspension were lower than those in solid state, excepted 439 
for CMIF for which no difference was seen between nanosuspension and solid form, the 440 
organic ligand giving a slightly higher protection against the quenching of luminescence by 441 
dioxygen. The luminescence quenching could also be reversed as seen with AQY value 442 
raising from 1.3 to 28% following 15 min N2 bubbling of CMIF solid loaded nanoparticles. 443 
From this study we can conclude that intrinsic properties of molybdenum cluster compound 444 
are not significantly modified when they are incorporated in PLGA nanoparticles.  445 
 446 
Conclusion 447 
Molybdenum cluster salts were successfully incorporated in PLGA matrixes leading to 448 
homogenous cluster loaded nanosuspensions characterized as efficient delivery systems. All 449 
nanoparticles had sizes compatible with cellular uptake, could quickly release their embedded 450 
cluster compound and exhibited good colloidal stabilities upon refrigeration. However, the 451 
tendency of cluster compounds to hydrolysis in water resulted in poor cluster chemical 452 
stability especially when the apical ligand was a halogen, limiting the shelf-life of the cluster 453 
loaded nanosuspensions. Thus, the development of a dry dosage form to be reconstituted 454 
extemporaneously before injection, capable to maintain cluster salts physico-chemical as well 455 
as photo-chemical properties for a longer period is of paramount importance. As cluster 456 
compounds photophysical properties are preserved when they are embedded into PLGA 457 
nanoparticles, their initial values are important to take into account before considering a 458 
biological application such as PDT. In vitro biological properties of these CNPs, i.e. cellular 459 
uptake, toxicity and photoactivity on ovarian cancer cells are currently under investigation.  460 
 461 
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 466 
 467 
 468 
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Figure captions 628 
Figure 1. General structure of hexanuclear molybdenum halide cluster unit (Mo6L
i
8L
a
6) 629 
where L
i 
and L
a
 represent inner (Br or I in our study) and apical (Br or (OOC2F5)6 in our 630 
study) ligands, respectively and A
+
 represents the counter cation ((C4H9)4N
+
 = TBA
+
 or Cs
+
 in 631 
our study). 632 
Figure 2. Characterization of CNPs (P/C ratio = 2.5). A) TEM images of TBA2 (left), CMIF 633 
(middle) and CMB (right) and B) photographs of water suspensions under daylight (left 634 
images / yellow colour) and UV light at 365 nm (right images / red phophorescence) for 635 
TBA2 (left), CMIF (middle) and CMB (right). 636 
Figure 3. Water suspended CNPs stability upon 3 months storage at 4°C and protected from 637 
light. Blank columns show particle size results, PDI are shown as lines and filled columns 638 
show zeta potential values (each bar is the mean  SD of  3 determinations). 639 
Figure 4. Water suspended CNPs UV-visible spectra evolution as a function of time (hour) 640 
for TBA2, CMIF and CMB (P/C ratio = 2.5). 641 
Figure 5. Percent cluster compound remaining unchanged at a function of time from water 642 
suspended CNPs with P/C ratios of 1 and 2.5. 643 
Figure 6. In vitro release study of cluster compound TBA2, CMIF and CMB from water 644 
suspended CNPs  with 3 different P/C ratios. Each point represents the mean ± SD of 3 645 
differents batches. 646 
Figure 7. Emission spectra recorded at λexc= 365 nm for TBA2 in powder (black signal) and 647 
for TBA2 loaded nanoparticles (P/C ratio = 2.5) as nanosuspension in water (greysignal) or 648 
solid form following freeze-drying of the nanosuspension (light grey signal).  649 
Figure 8. Left: Solid state emission spectra of CMIF (black) and CMIF loaded nanoparticles 650 
(P/C ratio = 2.5) (grey); Right: Solid state emission spectra of CMIF loaded nanoparticles 651 
with 3 different P/C ratios. 652 
Figure 9. Evolution of emission signal recorded at λexc= 365 nm for solid CMIF loaded 653 
nanoparticles (P/C = 2.5) with saturation of atmosphere with N2 654 
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Size (nm) 
 
 
PDI 
 
Zeta Potentiel (mV) 
TBA2 - PLGA
a 85.7 ± 4.9 0.12 ± 0.02 -25.8 ± 4.4 
CMIF - PLGAa 102.0 ± 2.6 0.16 ± 0.01 -38.2 ± 1.7 
CMB - PLGAa 75.7 ± 2.5 0.16 ± 0.02 -22.4 ± 9.8 
    
TBA2 - PLGA
b 95.0 ± 6.1 0.12 ± 0.01 -42.2 ± 8.0 
CMIF - PLGAb 124.7 ± 2.5 0.08 ± 0.02 -47.8 ± 4.6 
CMB - PLGAb 99.3 ± 4.6 0.12 ± 0.01 -47.8 ± 9.1 
    
TBA2 - PLGA
c 141.7 ± 6.4 0.09 ± 0.02 -24.8 ± 1.3 
CMIF - PLGAc 144.7 ± 4.7 0.09 ± 0.03 -31.5 ± 3.6 
CMB - PLGAc 118.3 ± 4.3 0.12 ± 0.01 -43.1 ± 6.5 
 
        P/C ratio a) 1; b) 2.5 and c) 5 
 
Table 1. Size (nm), polydispersity index (PDI) and zeta-potential (ZP) for all water suspended CNPs 
with 3 different P/C ratios (each value is the mean ± SD of 3 determinations). 
 
 
Table 1
 1 
 
 
 
 
EE % 
 
 
CL 
 
MY % 
TBA2 - PLGA
a 63.1 ± 7.5 50.9 ± 3.5 78.1 ± 10.2 
CMIF - PLGAa 68.1 ± 5.2 73.6 ± 12.9 83.1 ± 12.8 
CMB - PLGAa 61.7 ± 6.3 73.9 ± 9.4 69.2 ± 4.1 
    
TBA2 - PLGA
b 85.6 ± 12.1 38.0 ± 13.5 76.2 ± 4.8 
CMIF - PLGAb 96.3 ± 1.8 69.8 ± 6.5 78.4 ± 7.0 
CMB - PLGAb 70.3 ± 7.8 47.8 ± 12.0 67.7 ± 18.8 
    
TBA2 - PLGA
c 60.3 ± 4.5 29.2 ± 5.6 79.5 ± 7.1 
CMIF - PLGAc 96.9 ± 2.3 55.0 ± 9.4 81.0 ± 2.2 
CMB - PLGAc 81.4 ± 6.8 34.9 ± 3.0 72.1 ± 11.2 
 
 
   P/C ratio a) 1; b) 2.5 and c) 5 
 
 
Table 2. EE%, CL and MY% for all CNPs with 3 different P/C ratios (each value is the mean ± SD of 
3 determinations). 
 
Table 2
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P/C ratio a) 1; b) 2.5 and c) 5; n.d: result not determined 
Bold values mean significant shifts 
 
Table 3. FT-IR vibrations obtained with PLGA blank nanoparticles characteristic bonds and their 
mofification following cluster loading in PLGA nanoparticles. 
 
 
 
 
 
 
 
 
C=O 
stretching 
1749 cm-1 
 
 
C-0 ester 
stretching 
1088 cm-1 
 
Sp3 C-H 
bond 
2914 cm-1 
TBA2 - PLGA
a 1752 1088 2924 
CMIF - PLGAa 1750 1084 2922 
CMB - PLGAa 1751 1085 2921 
    
TBA2 - PLGA
b 1752 1080 2923 
CMIF - PLGAb 1752 1084 2922 
CMB - PLGAb 1751 1083 n.d. 
    
TBA2 - PLGA
c 1750 1084 2924 
CMIF - PLGAc 1749 1084 2923 
CMB - PLGAc 1750 1084 2923 
Table 3
 1 
 
 
 
 
 
 
 
 
a, b, c
: values obtained previously in our team (same experimental conditions and apparatus) by Amela-
Cortes (2014), Robin (2018) and Nayak (2015), respectively. 
 
Table 4. Emission maximum wavelengths (λem) and absolute quantum yield (em) values obtained at 
λexc = 365 nm for cluster compounds in solid state and CNPs in solid state or as nanosuspension in 
water. 
 
 
λem (nm) 
 
 
em solid state  
(in air)                   
 
 
em water suspension  
(aerated) 
TBA2  785 0.22
a n.d. 
TBA2 - NP 1 785 0.120 0.066 
TBA2 - NP 2.5 785 0.137 0.066 
TBA2 - NP 5 785 0.143 0.067 
    
CMIF  660 0.35
b n.d. 
CMIF - NP 1 675 0.013 0.014 
CMIF - NP 2.5 675 0.013 0.016 
CMIF - NP 5 675 0.017 0.016 
    
CMB 767 0.14
c n.d. 
CMB - NP 1 767 0.032 0.020 
CMB - NP 2.5 767 0.032 0.019 
CMB - NP 5 767 0.038 0.020 
Table 4
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